CYCLIZINE MEDSURGE cyclizine lactate 50 mg/1 mL injection ampoule
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
25-09-2023
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
cyclizine lactate, Quantity: 50 mg
Available from:
Micro Labs Pty Ltd
Pharmaceutical form:
Injection
Composition:
Excipient Ingredients: water for injections; lactic acid
Administration route:
Intravenous
Units in package:
1 mL clear glass ampoules. Five ampoules in a carton
Prescription type:
(S4) Prescription Only Medicine
Therapeutic indications:
Prevention of nausea and vomiting in the post operative period
Product summary:
Visual Identification: Clear, colourless to slightly yellow solution for injection; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius
Authorization status:
Registered
Authorization date:
2023-09-25
